The AlphaVac system is an efficient way to remove clot from large vessels. The system utilizes the proprietary funnel cannula technology, ergonomic reloadable handle, and transparent waste bag to achieve removal of clot with control.
Comfort and control while maintaining uninterrupted aspiration without disconnecting or resetting
No need for multiple placements of system
Dictate aspiration volume per pull of handle
Percutaneous mechanical thrombectomy may reduce length of stay (no ICU) and need for thrombolytic therapy1,2
| The AlphaVac System | F1885 | F2220 and F22180 |
| Access Sheath | 22F | 26F |
| Cannula Diameter | 18F | 22F |
| Working Length | 105cm | 77cm |
| Distal Angle | 85° | 20°/180° |
| Key Features and Benefits | Hemostatic Valve Proximal to Distal Control Braided Shaft Triple Durometer Shaft | Aspiration Lumen Flexibility Colled Shaft |
AngioDynamics does not provide medical advice, diagnosis, or treatment. The contents of this website, including disease state information, text, graphics, images, and other material (“Content”) are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition and the appropriate treatment for a particular medical condition.
Request a Sales Representative
Reimbursement Resources and C-Code Finder Lookup
For AlphaVac System document resources please visit alpha-vac.com/resources.
Dr. John Moriarty discusses the proprietary features and benefits of the AlphaVac F1885 System that advance treatment options for patients presenting with pulmonary embolism
The AlphaVac F1885 System provides operators the option to wirelessly navigate between pulmonary vasculature.
Learn about the workflow of the AlphaVac F1885 System.
AngioDynamics has sponsored two pivotal studies, APEX-AV and RECOVER-AV, aimed at evaluating the safety and efficacy of the AlphaVac F1885 system for the treatment of acute pulmonary embolism.
The Recover-AV Trial is a Prospective, Multicenter, Multinational Study Evaluating the Effectiveness and Safety of the Alphavac Multipurpose Mechanical Aspiration (MMA) F1885 System for the Treatment of Acute Intermediate Risk Pulmonary Embolism (PE).
Investigational Study to Assess the Performance of the AlphaVac F1885 System in the Treatment of Pulmonary Embolism (PE)
1. Karthikesalingam A, Young E L, Hinchliffe R J, Loftus I M, Thompson M M, Holt P J E,A Systematic Review of Percutaneous Mechanical Thrombectomy in the Treatment of Deep Venous Thrombosis. EJVES, 2011; 41(4): 554-565.
2. Muli Jogi RK, Damodharan K, Leong HL, et al. Catheter-directed thrombolysis versus percutaneous mechanical thrombectomy in the management of acute limb ischemia: a single center review. CVIR Endovasc. 2018;1(1):35.
AlphaVac and the AlphaVac logo are trademarks and/or registered trademarks of AngioDynamics, Inc., an affiliate or subsidiary.
